The Supreme Court
One way that states are trying to help patients deal with pain and other difficulties faced when seriously or terminally ill is by permitting the use of marijuana for medicinal purposes. This choice is in direct conflict with the federal government's attempts to control illegal drugs.
President Bush ordered the U.S. Justice Department to step up enforcement efforts in states that enacted laws that permit doctors to recommend marijuana. These states include Alaska, Arizona, California, Colorado, Hawaii, Maine, Nevada, Oregon, and Washington. So far only one case has made it all the way to the Supreme Court—United States v. Oakland Cannabis Buyers Cooperative. This case did not involve a physician, but instead involved a cooperative where people bought the prescribed marijuana or cannabis.
The cooperative is a not-for-profit organization that operates in downtown Oakland. Its medical director is a physician and there are registered nurses on staff during business hours. In order to become a member of the cooperative a patient must have a written statement from a treating physician that states marijuana therapy will help and must submit to a screening interview. If accepted the patient will receive an identification card that allows him or her to obtain marijuana from the cooperative.
In January 1998, the United States government sued the cooperative and its executive director, Jeffrey Jones, in district court seeking to stop the cooperative from distributing marijuana. Even though the cooperative's activities are legal in California, distributing and manufacturing of marijuana, a controlled substance, violates the federal Controlled Substances Act. The district court granted a preliminary injunction to stop the cooperative.
The cooperative did not appeal the injunction, but instead continued to violate the law by distributing marijuana. The U.S. government then initiated contempt proceedings against the cooperative. The cooperative contended that marijuana is the only drug that can alleviate the pain and other debilitating symptoms of the cooperative's patients. The district court didn't buy that argument, found the cooperative in contempt and gave the U.S. Marshal the power to seize the cooperative's premises. The cooperative filed a motion to modify the injunction to permit distributions that were medically necessary, which was rejected by the district court. The cooperative appealed the case to the 9th Circuit Court, which ruled the district court should have weighted the “public interest” and considered “factors such as the serious harm in depriving patients of marijuana.” The district court then modified its injunction to incorporate the medically necessary defense.
National Review Senior Editor Richard Brookhiser, who used marijuana to cope with the agony of chemotherapy during his bout with cancer, wrote, “My support for medical marijuana is not a contradiction of my principles, but an extension of them. I am for law and order, but crime has to be fought intelligently, and the law disgraces itself when it harasses the sick. I support the Christian Coalition and supported the moral majority, but carrying your moral beliefs to unjust ends is not moral, it is philistine. More importantly, I believe in getting government off people's backs. We should include the backs of sick people trying to help themselves.”
The U.S. government then appealed to the Supreme Court questioning the circuit court's ruling that medical necessity is a legally cognizable defense to violations of the Controlled Substances Act. The Court ruled unanimously to overturn the circuit court and decided there was no medical necessity exception to the Controlled Substances Act's prohibitions on manufacturing and distributing marijuana. Justice Thomas wrote the opinion for the Court and was joined by Chief Justice Rehnquist and Justices Kennedy, O'Connor and Scalia. Justice Stevens filed a concurring opinion and was joined by Justices Ginsburg and Souter. Justice Breyer did not participate in this case.
Justice Thomas wrote for the Court on May 14, 2001:
In an attempt to fix this problem Congressman Barney Frank (D-Massachusetts) introduced a bill in 2001 and again on May 22, 2003, called the “States Rights to Medical Marijuana Act.” This bill moves marijuana from the Schedule I of the Controlled Substances Act to Schedule II, which allows more flexibility. It also allows:
Just the Facts
As part of a U.S. Justice Department effort to punish clinic directors who provide medical marijuana, the president of the Los Angeles Cannabis Resource Center, Scott Imler, faced a maximum of 20 years in prison and a fine of up to $500,000 after accepting a plea bargain in July 2003 on federal charges of maintaining a drug establishment. The actual sentence was reduced to just one year of probation, the minimum allowable sentence. U.S. District Judge A. Howard Matz reprimanded the prosecution, stating that “to allocate the resources of the Drug Enforcement Agency and the U.S. attorney's office in this case baffles me, disturbs me.”
In October 2003, the Supreme Court decided not to take a related case involving whether doctors could inform patients about the use of medical marijuana. By not taking the case the Supreme Court let stand a lower court ruling that doctors may not be investigated, threatened, or punished by federal regulators for recommending marijuana as a medical treatment for their patients.
This ruling allows doctors in the states that permit marijuana for medical uses to discuss this option freely with their patients without fear a losing of their license to prescribe drugs. As part of the war on drugs, the Bush Administration hoped to overturn these state laws. These hopes were dashed by the Court's decision not to take the case. Medical marijuana advocates hope to use this victory to encourage other states to pass similar laws.
Excerpted from The Complete Idiot's Guide to The Supreme Court © 2004 by Lita Epstein, J.D.. All rights reserved including the right of reproduction in whole or in part in any form. Used by arrangement with Alpha Books, a member of Penguin Group (USA) Inc.